Xiaoping Ma
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Ophthalmology top 5%
Papers in
-
- RNA modifications and cancer 5
- Protein Kinase Regulation and GTPase Signaling 4
- Epigenetics and DNA Methylation 4
- Circular RNAs in diseases 4
-
- MicroRNA in disease regulation 4
- Cancer-related molecular mechanisms research 3
- Co-authors
- Dharini van der Hoeven (5 shared papers)John F. Hancock (5 shared papers)Kwang-Jin Cho (2 shared papers)Sravanthi Chigurupati (1 shared paper)Robert G. Parton (1 shared paper)Yong Zhou (2 shared papers)Yu Wu (4 shared papers)Wei Chen (1 shared paper)
- Journals
- Molecular and Cellular Biology (3 papers)Frontiers in Genetics (3 papers)Current Cancer Drug Targets (2 papers)Saudi Journal of Biological Sciences (1 paper)Life Science Alliance (1 paper)
- Partner nations
- ChinaUnited StatesThailand
In The Last Decade
Xiaoping Ma
52 papers receiving 875 citations
Peers
Comparison fields: 5 of 94
- Cancer Research 193
- Ophthalmology 60
- Cell Biology 116
- Molecular Biology 466
- Oncology 81
Countries citing papers authored by Xiaoping Ma
This map shows the geographic impact of Xiaoping Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoping Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoping Ma more than expected).
Fields of papers citing papers by Xiaoping Ma
This network shows the impact of papers produced by Xiaoping Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoping Ma. The network helps show where Xiaoping Ma may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoping Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 57 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 91 | |
| 2 | 2015 | 86 | |
| 3 | 2014 | 41 | |
| 4 | 2017 | 39 | |
| 5 | 2020 | 39 | |
| 6 | 2014 | 37 | |
| 7 | 2016 | 34 | |
| 8 | 2019 | 31 | |
| 9 | 2018 | 29 | |
| 10 | 2024 | 29 | |
| 11 | 2009 | 29 | |
| 12 | 2021 | 28 | |
| 13 | 2014 | 27 | |
| 14 | 2015 | 24 | |
| 15 | 2015 | 22 | |
| 16 | 2018 | 22 | |
| 17 | 2011 | 19 | |
| 18 | Relationship between epidermal growth factor receptor (EGFR) mutation and serum cyclooxygenase-2 Level, and the synergistic effect of celecoxib and gefitinib on EGFR expression in non-small cell lung cancer cells. | 2015 | 18 |
| 19 | 2013 | 17 | |
| 20 | 2018 | 17 |
About Xiaoping Ma
Xiaoping Ma is a scholar working on Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Public Health, Environmental and Occupational Health and Cell Biology, having authored 57 papers that have together received 888 indexed citations. Recurring topics across this work include RNA modifications and cancer (5 papers), Cellular transport and secretion (4 papers), Protein Kinase Regulation and GTPase Signaling (4 papers), Epigenetics and DNA Methylation (4 papers), Ocular Surface and Contact Lens (4 papers), Circular RNAs in diseases (4 papers), MicroRNA in disease regulation (4 papers) and Cancer-related molecular mechanisms research (3 papers). The work is most often cited by research in Cancer Research (193 citations), Ophthalmology (60 citations), Cell Biology (116 citations), Molecular Biology (466 citations) and Oncology (81 citations). Xiaoping Ma has collaborated with scholars based in China, United States and Thailand. Frequent co-authors include Dharini van der Hoeven, John F. Hancock, Kwang-Jin Cho, Sravanthi Chigurupati, Robert G. Parton, Yong Zhou, Yu Wu, Wei Chen, Masashi Maekawa and Peishu Liu. Their work appears in journals such as Molecular and Cellular Biology, Frontiers in Genetics, Current Cancer Drug Targets, Saudi Journal of Biological Sciences and Life Science Alliance.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.